Sun 15 Nov 2026 00:34:03 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

RTF Template


National Authority Of Medicines And Health Products

UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

Human medicinal products


1. Authorisation Number

:

A017/17/H/006/2025

2. Name of Authorisation Holder

:

Addo Distribuicao Unipessoal Lda.

(ORG-100036934 / LOC-100058353)

3. Address(es) of Site(s)

:

Estrada Nacional 9 Km 17, Terrugem, Terrugem Snt, 2709-504, Portugal 

Armazem 8, Avenida De Santa Isabel No. 69, Cabra Figa, Rio De Mouro, 2635-047, Portugal 




4. Legally registered address of Authorisation Holder

:

Avenida Pedro Nunes N 10 B, Rio De Mouro, 2635-317, Portugal

5. Scope of authorisation (complete for each site under 4)

:

ANNEX 1

6. Legal basis of authorisation

:

Art. 77(1) of Directive 2001/83/EC
National legal basis of authorisation: Art. 94.º of Decree-law 176/2006, of 30th August.

7. Name of responsible officer of the competent authority of the member state granting the wholesaling authorisation

:

Confidential, Confidential

8. Signature

:


9. Date

:

2025-04-02

10. Annexes attached

:

Annex 1 Scope of wholesale distribution authorisation

Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

Annex 3 (Optional) Name(s) of responsible person(s)

Annex 4 (Optional) Date of Inspection on which authorisation was granted

Annex 5 (Optional) Additional provisions based on national requirements


ANNEX 1

SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



Name and address of the site: Addo Distribuicao Unipessoal Lda.

(ORG-100036934 / LOC-100066562)

, Estrada Nacional 9 Km 17, Terrugem, Terrugem Snt, 2709-504, Portugal   



Human medicinal products


1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation or registration in EEA country(s)


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 


3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

   3.2. Products requiring low temperature handling 

     3.2.1. Temperatures between 2 to 8 °C 

   3.3. Other products: (please specify here or make a reference to Annex 5) Immunological.




Any restrictions or clarifying remarks (for all users):  WDA scope activity - Wholesale Distributor.

Updating the WDA by the inclusion of one more site.


Name and address of the site: Addo Distribuicao Unipessoal Lda.

(ORG-100036934 / LOC-100093666)

, Armazem 8, Avenida De Santa Isabel No. 69, Cabra Figa, Rio De Mouro, 2635-047, Portugal   



Human medicinal products


1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation or registration in EEA country(s)


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 


3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

   3.1. Narcotic or psychotropic products** 

   3.2. Products requiring low temperature handling 

     3.2.1. Temperatures between 2 to 8 °C 

   3.3. Other products: (please specify here or make a reference to Annex 5) Immunological and Homeopathic Medicinal Products.




Any restrictions or clarifying remarks (for all users):  WDA scope activity - Wholesale Distributor.

Updating the WDA by the inclusion of this new site.



**Without prejudice to further authorisations as may be required according to national legislation.













Union Format for a Wholesale Distribution Authorisation

A017/17/H/006/2025


Page 1





Loading, please wait